Abstract
The retinoic acid receptor-related orphan receptor (ROR) subfamily of nuclear receptors are transcription factors involved in the maintenance of circadian rhythm and are essential for proper immune function. The T cell-specific isoform, RORγt, is required for T helper 17 cells (TH17) development and it has been implicated in the pathogenesis of autoimmune diseases including multiple sclerosis and rheumatoid arthritis. Thus, pharmacological repression of RORγt may provide a strategy for therapeutic intervention in autoimmune disorders. This chapter provides a summary of the current status for target validation and development of new chemical entities targeting RORγt.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alonzi T et al (1998) Interleukin 6 is required for the development of collagen-induced arthritis. J Exp Med 187(4):461–468
Andre E et al (1998a) Disruption of retinoid-related orphan receptor beta changes circadian behavior, causes retinal degeneration and leads to vacillans phenotype in mice. EMBO J 17(14):3867–3877
Andre E, Gawlas K, Becker-Andre M (1998b) A novel isoform of the orphan nuclear receptor RORbeta is specifically expressed in pineal gland and retina. Gene 216(2):277–283
Barish GD et al (2005) A nuclear receptor atlas: macrophage activation. Mol Endocrinol 19(10):2466–2477
Becker-Andre M, Andre E, DeLamarter JF (1993) Identification of nuclear receptor mRNAs by RT-PCR amplification of conserved zinc-finger motif sequences. Biochem Biophys Res Commun 194(3):1371–1379
Bertolini DR et al (1986) Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature 319(6053):516–518
Burris TP (2008) Nuclear hormone receptors for heme: REV-ERB alpha and REV-ERB beta are ligand-regulated components of the mammalian clock. Mol Endocrinol 22(7):1509–1520
Chang MR et al (2014) Pharmacological repression of RORgamma is therapeutic in the collagen-induced arthritis experimental model. Arthritis Rheumatd 66(3):579--588
Carlberg C et al (1994) RZRs, a new family of retinoid-related orphan receptors that function as both monomers and homodimers. Mol Endocrinol 8(6):757–770
Clinckemalie L et al (2012) The hinge region in androgen receptor control. Mol Cell Endocrinol 358(1):1–8
Dayer JM, Beutler B, Cerami A (1985) Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J Exp Med 162(6):2163–2168
Duerr RH et al (2006) A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314(5804):1461–1463
Evans RM (1988) The steroid and thyroid hormone receptor superfamily. Science 240(4854):889–895
Fossiez F et al (1996) T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med 183(6):2593–2603
Fujiwara N, Kobayashi K (2005) Macrophages in inflammation. Curr Drug Targets Inflamm Allergy 4(3):281–286
Gaffen SL (2008) An overview of IL-17 function and signaling. Cytokine 43(3):402–407
Genovese MC et al (2010) LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study. Arthritis Rheum 62(4):929–939
Griffin PR et al (2011) Modulators of the retinoic acid receptor-related orphan receptors. The Scripps Research Institute. WO 2011115892
Giguere V et al (1994) Isoform-specific amino-terminal domains dictate DNA-binding properties of ROR alpha, a novel family of orphan hormone nuclear receptors. Genes Dev 8(5):538–553
Gu Y et al (2008) Interleukin 10 suppresses Th17 cytokines secreted by macrophages and T cells. Eur J Immunol 38(7):1807–1813
Hamilton BA et al (1996) Disruption of the nuclear hormone receptor RORalpha in staggerer mice. Nature 379(6567):736–739
Heery DM et al (1997) A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 387(6634):733–736
Hirose T, Smith RJ, Jetten AM (1994) ROR gamma: the third member of ROR/RZR orphan receptor subfamily that is highly expressed in skeletal muscle. Biochem Biophys Res Commun 205(3):1976–1983
Hot A, Miossec P (2011) Effects of interleukin (IL)-17A and IL-17F in human rheumatoid arthritis synoviocytes. Ann Rheum Dis 70(5):727–732
Hu X, Lazar MA (1999) The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors. Nature 402(6757):93–96
Ivanov II et al (2006) The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126(6):1121–1133
Jetten AM (2009) Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism. Nucl Recept Signal 7:e003
Jetten AM, Kurebayashi S, Ueda E (2001) The ROR nuclear orphan receptor subfamily: critical regulators of multiple biological processes. Prog Nucleic Acid Res Mol Biol 69:205–247
Joosten LA et al (1999) IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation. J Immunol 163(9):5049–5055
Kamenecka TM et al (2013) Synthetic modulators of the retinoic acid receptor-related orphan receptors. Medchemcomm 4(5):764–776
Kishimoto T (2005) Interleukin-6: from basic science to medicine–40 years in immunology. Annu Rev Immunol 23:1–21
Koenders MI et al (2005) Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1. Am J Pathol 167(1):141–149
Kolls JK, Linden A (2004) Interleukin-17 family members and inflammation. Immunity 21(4):467–476
Korn T et al (2009) IL-17 and Th17 Cells. Annu Rev Immunol 27:485–517
Kotake S et al (1999) IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 103(9):1345–1352
Krasowski MD, Reschly EJ, Ekins S (2008) Intrinsic disorder in nuclear hormone receptors. J Proteome Res 7(10):4359–4372
Kumar N et al (2010a) Campaign to identify novel modulators of the retinoic acid receptor-related orphan receptors (ROR). Probe Reports from the NIH Molecular Libraries Program
Kumar N et al (2010) The benzenesulfoamide T0901317 [N-(2, 2, 2-trifluoroethyl)-N-[4-[2, 2, 2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethy l]phenyl]-benzenesulfonamide] is a novel retinoic acid receptor-related orphan receptor-alpha/gamma inverse agonist. Mol Pharmacol 77(2):228–236
Kumar N et al (2012) Identification of SR2211: a potent synthetic RORgamma-selective modulator. ACS Chem Biol 7(4):672–677
Lubberts E, Koenders MI, van den Berg WB (2005) The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models. Arthritis Res Ther 7(1):29–37
Miossec P (2007) Interleukin-17 in fashion, at last: ten years after its description, its cellular source has been identified. Arthritis Rheum 56(7):2111–2115
Moore JT, Collins JL, Pearce KH (2006) The nuclear receptor superfamily and drug discovery. Chem Med Chem 1(5):504–523
Nair RP et al (2009) Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet 41(2):199–204
Overington JP, Al-Lazikani B, Hopkins AL (2006) How many drug targets are there? Nat Rev Drug Discov 5(12):993–996
Park MC et al (2010) Liver X receptor agonist prevents the evolution of collagen-induced arthritis in mice. Rheumatol (Oxford) 49(5):882–890
Privalsky ML (2004) The role of corepressors in transcriptional regulation by nuclear hormone receptors. Annu Rev Physiol 66:315–360
Raghuram S et al (2007) Identification of heme as the ligand for the orphan nuclear receptors REV-ERB alpha and REV-ERB beta. Nat Struct Mol Biol 14(12):1207–1213
Smolen JS et al (1995) Validity and reliability of the twenty-eight-joint count for the assessment of rheumatoid arthritis activity. Arthritis Rheum 38(1):38–43
Solt LA et al (2011) Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand. Nature 472(7344):491–494
Solt LA et al (2012) Identification of a selective RORgamma ligand that suppresses T(H)17 cells and stimulates T regulatory cells. ACS Chem Biol 7(9):1515–1519
Song C et al (2008) IL-17-producing alveolar macrophages mediate allergic lung inflammation related to asthma. J Immunol 181(9):6117–6124
Spencer TE et al (1997) Steroid receptor coactivator-1 is a histone acetyltransferase. Nature 389(6647):194–198
Stahl EA et al (2010) Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet 42(6):508–514
Steinmayr M et al (1998) Staggerer phenotype in retinoid-related orphan receptor alpha-deficient mice. Proc Natl Acad Sci U S A 95(7):3960–3965
Sun Z et al (2000) Requirement for RORgamma in thymocyte survival and lymphoid organ development. Science 288(5475):2369–2373
Takemura S et al (2001) Lymphoid neogenesis in rheumatoid synovitis. J Immunol 167(2):1072–1080
Tesmer LA et al (2008) Th17 cells in human disease. Immunol Rev 223:87–113
Toy D et al (2006) Cutting edge: interleukin 17 signals through a heteromeric receptor complex. J Immunol 177(1):36–39
Tremblay GB et al (1999) Dominant activity of activation function 1 (AF-1) and differential stoichiometric requirements for AF-1 and -2 in the estrogen receptor alpha-beta heterodimeric complex. Mol Cell Biol 19(3):1919–1927
van de Veerdonk FL et al (2011) The anti-CD20 antibody rituximab reduces the Th17 cell response. Arthritis Rheum 63(6):1507–1516
van den Berg WB, Miossec P (2009) IL-17 as a future therapeutic target for rheumatoid arthritis. Nat Rev Rheumatol 5(10):549–553
Wang Y et al (2010) Modulation of retinoic acid receptor-related orphan receptor alpha and gamma activity by 7-oxygenated sterol ligands. J Biol Chem 285(7):5013–5025
Warnmark A et al (2003) Activation functions 1 and 2 of nuclear receptors: molecular strategies for transcriptional activation. Mol Endocrinol 17(10):1901–1909
Yang XO et al (2008) T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity 28(1):29–39
Yu Q et al (2004) IL-7 receptor signals inhibit expression of transcription factors TCF-1, LEF-1, and RORgammat: impact on thymocyte development. J Exp Med 200(6):797–803
Zwart W et al (2010) The hinge region of the human estrogen receptor determines functional synergy between AF-1 and AF-2 in the quantitative response to estradiol and tamoxifen. J Cell Sci 123(Pt 8):1253–1261
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Chang, M.R., Rosen, H., Griffin, P.R. (2014). RORs in Autoimmune Disease. In: Oldstone, M., Rosen, H. (eds) Sphingosine-1-Phosphate Signaling in Immunology and Infectious Diseases. Current Topics in Microbiology and Immunology, vol 378. Springer, Cham. https://doi.org/10.1007/978-3-319-05879-5_8
Download citation
DOI: https://doi.org/10.1007/978-3-319-05879-5_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-05878-8
Online ISBN: 978-3-319-05879-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)